Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marc C Hochberg & René Rizzoli. (2006) Long-term experience with alendronate in the treatment of osteoporosis. Expert Opinion on Pharmacotherapy 7:9, pages 1201-1210.
Read now
Read now
Articles from other publishers (54)
Ziaul H. Rana, Megan W. Bourassa, Filomena Gomes, Anuradha Khadilkar, Rubina Mandlik, Victor Owino, John M. Pettifor, Daniel E. Roth, Julie Shlisky, Prashanth Thankachan & Connie M. Weaver. (2022) Calcium status assessment at the population level: Candidate approaches and challenges. Annals of the New York Academy of Sciences 1517:1, pages 93-106.
Crossref
Crossref
Arata Akaike, Daisuke Suzuki, Shinya Okuyama, Yutaro Kudo, Hiroyasu Shimizu, Sara Takanashi, Kohei Makino, Junichi Yokoyama & Shigeyuki Nakaji. (2022) Associations between physical physique/fitness in children and bone development during puberty: a 4-year longitudinal study. Scientific Reports 12:1.
Crossref
Crossref
Takuma Okamura, Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, Yasuhide Motoyoshi, Mio Yamashima, Shinobu Yamamichi, Makiko Koike, Yusuke Nakano, Tetsurou Honda, Hiroyuki Yajima, Osamu Miyazaki, Yasutaka Kuribayashi, Tomonari Ikeda, Naota Taura & Kazuhiko Nakao. (2021) Change in tartrate‑resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide. Biomedical Reports 16:1.
Crossref
Crossref
Arina Miyoshi, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi & Hideaki Miyoshi. (2020) Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. Journal of Diabetes Investigation 12:7, pages 1293-1300.
Crossref
Crossref
Dima L. Diab, Nelson B. Watts & Paul D. Miller. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
1721
1736
.
Keisuke Yasuda, Shinsuke Okada, Yohei Okazaki, Kyou Hiasa, Kazuhiro Tsuga & Yasuhiko Abe. (2020) Bone turnover markers to assess jawbone quality prior to dental implant treatment: a case-control study. International Journal of Implant Dentistry 6:1.
Crossref
Crossref
Daiki Suehiro, Ayaka Nishio, Junya Kawai, Ken Fukami & Motoko Ohnishi. (2020) Effects of corn syrup solids containing maltobionic acid (maltobionic acid calcium salt) on bone resorption in healthy Japanese adult women: A randomized double‐blind placebo‐controlled crossover study. Food Science & Nutrition 8:2, pages 1030-1037.
Crossref
Crossref
Patrick Garnero & Serge Cremers. 2020. Principles of Bone Biology. Principles of Bone Biology
1801
1832
.
Kathryn I. Marko. 2019. Office Gynecology. Office Gynecology
307
310
.
So Mi Kim, Hyun Sook Lee, Jae In Jung, Su-Min Lim, Ji Hoon Lim, Wang-Hyun Ha, Chang Lae Jeon, Jae-Yong Lee & Eun Ji Kim. (2018) Effect of isoflavone-enriched whole soy milk powder supplementation on bone metabolism in ovariectomized mice. Nutrition Research and Practice 12:4, pages 275.
Crossref
Crossref
Sydney L. Bonnick. 2015. Rheumatology. Rheumatology
349
357
.
Ramin Rasoulian, Ahmad Raeisi Najafi, Michael Chittenden & Iwona Jasiuk. (2013) Reference point indentation study of age-related changes in porcine femoral cortical bone. Journal of Biomechanics 46:10, pages 1689-1696.
Crossref
Crossref
Dima L. Diab, Nelson B. Watts & Paul D. Miller. 2013. Osteoporosis. Osteoporosis
1859
1872
.
Mohammad F Souzanchi, Paolo Palacio‐Mancheno, Yury A Borisov, Luis Cardoso & Stephen C Cowin. (2012) Microarchitecture and bone quality in the human calcaneus: Local variations of fabric anisotropy. Journal of Bone and Mineral Research 27:12, pages 2562-2572.
Crossref
Crossref
Paul D. Miller, Sophie A. Jamal & Sarah L. West. (2012) Bone Mineral Density in Chronic Kidney Disease Use and Misuse. Clinical Reviews in Bone and Mineral Metabolism 10:3, pages 163-173.
Crossref
Crossref
Carmen M. Romero Barco, Sara Manrique Arija & Manuel Rodríguez Pérez. (2012) Biochemical Markers in Osteoporosis: Usefulness in Clinical Practice. Reumatología Clínica (English Edition) 8:3, pages 149-152.
Crossref
Crossref
Kyoko Taku, Melissa K. Melby, Nobuo Nishi, Toyonori Omori & Mindy S. Kurzer. (2011) Soy isoflavones for osteoporosis: An evidence-based approach. Maturitas 70:4, pages 333-338.
Crossref
Crossref
Carmen M. Romero Barco, Sara Manrique Arija & Manuel Rodríguez Pérez. (2011) Marcadores bioquímicos en osteoporosis. Utilidad en la práctica clínica. Reumatología Clínica.
Crossref
Crossref
Sydney Bonnick. 2011. Rheumatology. Rheumatology
399
411
.
E. Michael Lewiecki. (2010) Monitoring pharmacological therapy for osteoporosis. Reviews in Endocrine and Metabolic Disorders 11:4, pages 261-273.
Crossref
Crossref
Paul D. Miller, Pierre D. Delmas, Hermann Huss, Katie M. Patel, Ralph C. Schimmer, Silvano Adami & Robert R. Recker. (2010) Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate. Calcified Tissue International 87:4, pages 305-313.
Crossref
Crossref
Kyoko Taku, Melissa K. Melby, Mindy S. Kurzer, Shoichi Mizuno, Shaw Watanabe & Yoshiko Ishimi. (2010) Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials. Bone 47:2, pages 413-423.
Crossref
Crossref
Paul D. Miller. (2010) All Bisphosphonates Are (or May Not Be) the Same: Potential Reasons for Clinical Differences. Journal of Women's Health 19:4, pages 665-669.
Crossref
Crossref
. (2010) Management of osteoporosis in postmenopausal women. Menopause 17:1, pages 25-54.
Crossref
Crossref
Paul D. Miller. 2010. Osteoporosis in Men. Osteoporosis in Men
453
463
.
M Takakuwa, K Otsuka, M Konishi & K Itabashi. (2009) Evaluation of the Effect of 4 Months of Risedronate Therapy on Femoral Strength Using Femoral Strength Analysis Tools. Journal of International Medical Research 37:6, pages 1972-1981.
Crossref
Crossref
E. Michael Lewiecki, Sanford Baim, John P. Bilezikian, Richard Eastell, Meryl S. LeBoff & Paul D. Miller. (2009) 2008 Santa Fe Bone Symposium: Update on Osteoporosis. Journal of Clinical Densitometry 12:2, pages 135-157.
Crossref
Crossref
Paul D. Miller. (2009) Diagnosis and Treatment of Osteoporosis in Chronic Renal Disease. Seminars in Nephrology 29:2, pages 144-155.
Crossref
Crossref
Paul D. Miller. (2008) Anti-resorptives in the management of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 22:5, pages 849-868.
Crossref
Crossref
A.I. Sebba, S. Broy, J.D. Kohles & P. Weissman. (2008) Rapid Suppression of Bone Resorption Marker Levels With Ibandronate Therapy in a Bisphosphonate-Naïve Population. Journal of Clinical Densitometry 11:3, pages 417-423.
Crossref
Crossref
Akinori Sakai, Toshihisa Oshige, Yukichi Zenke, Masahiro Suzuki, Yoshiaki Yamanaka & Toshitaka Nakamura. (2008) Association of Bone Mineral Density With Deformity of the Distal Radius in Low-Energy Colles' Fractures in Japanese Women Above 50 Years of Age. The Journal of Hand Surgery 33:6, pages 820-826.
Crossref
Crossref
D. M. Reid, D. Hosking, D. Kendler, M. L. Brandi, J. D. Wark, J. F. Marques-Neto, G. Weryha, N. Verbruggen, C. M. Hustad, E. M. Mahlis & M. E. Melton. (2008) A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International. International Journal of Clinical Practice 62:4, pages 575-584.
Crossref
Crossref
Paul D. Miller. (2008) Skeletal Health and Bone Strength: DXA and Beyond Growth for the Journal of Clinical Densitometry. Journal of Clinical Densitometry 11:1, pages 1-5.
Crossref
Crossref
PAUL D. MILLER. 2008. Osteoporosis. Osteoporosis
1725
1742
.
Paul D. Miller. 2008. Principles of Bone Biology. Principles of Bone Biology
1895
1904
.
T. W. Weiss, E. S. Siris, E. Barrett-Connor, P. D. Miller & C. A. McHorney. (2007) Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study. Osteoporosis International 18:11, pages 1473-1480.
Crossref
Crossref
Peter Fratzl, Paul Roschger, Nadja Fratzl-Zelman, Eleftherios P. Paschalis, Roger Phipps & Klaus Klaushofer. (2007) Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume. Calcified Tissue International 81:2, pages 73-80.
Crossref
Crossref
V. Lilleby. (2016) Review: Bone status in juvenile systemic lupus erythematosus. Lupus 16:8, pages 580-586.
Crossref
Crossref
Felicia Cosman, Joao L.C. Borges & Manuel Diaz Curiel. (2007) Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: The role of comparative studies and implications for future studies. Clinical Therapeutics 29:6, pages 1116-1127.
Crossref
Crossref
Paul D. Miller. (2007) Monitoring osteoporosis therapies. Current Osteoporosis Reports 5:1, pages 38-43.
Crossref
Crossref
Angelo A Licata. (2007) Clinical Perspectives on Bone Quality in Osteoporosis. Drugs & Aging 24:7, pages 529-535.
Crossref
Crossref
J.C. Gallagher, C.J. Rosen, P. Chen, D.A. Misurski & R. Marcus. (2006) Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis. Bone 39:6, pages 1268-1275.
Crossref
Crossref
Peiqi Chen, Paul D Miller, Pierre D Delmas, Derek A Misurski & John H Krege. (2006) Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide-Treated Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research 21:11, pages 1785-1790.
Crossref
Crossref
R. O. Ritchie, R. K. Nalla, J. J. Kruzic, J. W. Ager, G. Balooch & J. H. Kinney. (2006) Fracture and Ageing in Bone: Toughness and Structural Characterization. Strain 42:4, pages 225-232.
Crossref
Crossref
J.W. AgerIIIIII, G. Balooch & R.O. Ritchie. (2006) Fracture, aging, and disease in bone. Journal of Materials Research 21:8, pages 1878-1892.
Crossref
Crossref
R. Jugdaohsingh, M. A. O'Connell, S. Sripanyakorn & J. J. Powell. (2007) Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proceedings of the Nutrition Society 65:3, pages 291-310.
Crossref
Crossref
Hui-Ying Huang, Hsiao-Ping Yang, Hui-Ting Yang, Tung-Chuan Yang, Ming-Jer Shieh & Shih-Yi Huang. (2006) One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect. The Journal of Nutritional Biochemistry 17:8, pages 509-517.
Crossref
Crossref
Ruth Zoehrer, Paul Roschger, Eleftherios P Paschalis, Jochen G Hofstaetter, Erich Durchschlag, Peter Fratzl, Roger Phipps & Klaus Klaushofer. (2006) Effects of 3- and 5-Year Treatment With Risedronate on Bone Mineralization Density Distribution in Triple Biopsies of the Iliac Crest in Postmenopausal Women. Journal of Bone and Mineral Research 21:7, pages 1106-1112.
Crossref
Crossref
Brian M Miller, Sheel M Patel & Denise R Sokos. (2016) Combining Bisphosphonates with Raloxifene to Treat Osteoporosis: A Review of the Evidence. Journal of Pharmacy Technology 22:4, pages 215-220.
Crossref
Crossref
. (2006) Management of osteoporosis in postmenopausal women. Menopause 13:3, pages 340-367.
Crossref
Crossref
Eunice Y. Pyon. (2006) Once-monthly Ibandronate for postmenopausal Osteoporosis: Review of a new dosing regimen. Clinical Therapeutics 28:4, pages 475-490.
Crossref
Crossref
David M Reid, David Hosking, David Kendler, Maria L Brandi, John D Wark, Georges Weryha, Jo??o F Marques-Neto, Keavy A Gaines, Nadia Verbruggen & Mary E Melton. (2006) Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone??Density and Turnover in Postmenopausal Women with Osteoporosis. Clinical Drug Investigation 26:2, pages 63-74.
Crossref
Crossref
Paul D. Miller. 2006. Osteoporosis and the Osteoporosis of Rheumatic Diseases. Osteoporosis and the Osteoporosis of Rheumatic Diseases
192
202
.
Paul D. Miller. (2005) Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Current Osteoporosis Reports 3:3, pages 103-110.
Crossref
Crossref